Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the safety of bevacizumab in combination with carboplatin and paclitaxel therapy for metastatic, recurrent or persistent cervical cancer, as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula events
Critère d'inclusion
- Metastatic, Recurrent or Persistent Cervical Cancer